▶ 調査レポート

世界のフェイシャルスキンアブレイティブトリートメント市場 2028年:高周波(RF)マイクロニードル、皮膚充填剤、レーザー皮膚リサーフェシング、メソセラピー

• 英文タイトル:Global Facial Skin Ablative Treatment Market Insights, Forecast to 2028

Global Facial Skin Ablative Treatment Market Insights, Forecast to 2028「世界のフェイシャルスキンアブレイティブトリートメント市場 2028年:高周波(RF)マイクロニードル、皮膚充填剤、レーザー皮膚リサーフェシング、メソセラピー」(市場規模、市場予測)調査レポートです。• レポートコード:QY2207C3458
• 出版社/出版日:QYResearch / 2022年7月11日
• レポート形態:英文、PDF、129ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のフェイシャルスキンアブレイティブトリートメントの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフェイシャルスキンアブレイティブトリートメントの世界市場のxxx%を占める「高周波(RF)マイクロニードル」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「シワ」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のフェイシャルスキンアブレイティブトリートメントの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのフェイシャルスキンアブレイティブトリートメント市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのフェイシャルスキンアブレイティブトリートメント市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

フェイシャルスキンアブレイティブトリートメントのグローバル主要メーカーには、Alma Lasers Ltd.、Lumenis Ltd.、Syneron Medical Ltd.、Cutera Inc.、Sciton Inc.、EL.EN. S.p.A.、Laseroptek Co. Ltd.、Fotona D.o.o.、Imdad LLC、Hologic Inc.、Stryker Corporation、Crown Laboratories Inc.、Delasco LLC、Lutronic Corp.、INSTITUTE BCN ESTHETICS SL、Koru Pharmaceuticals Co. Ltd.、CAREGEN Co. LTD.、HUGEL Inc.、Allergan plc、Galderma SA、Merz Pharma GmbH & Co. KGaA、Shenb Co. Ltd.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

フェイシャルスキンアブレイティブトリートメント市場は、種類と用途によって区分されます。世界のフェイシャルスキンアブレイティブトリートメント市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
高周波(RF)マイクロニードル、皮膚充填剤、レーザー皮膚リサーフェシング、メソセラピー

【用途別セグメント】
シワ、老化、ニキビ&傷跡、色素沈着過剰、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- フェイシャルスキンアブレイティブトリートメント製品概要
- 種類別市場(高周波(RF)マイクロニードル、皮膚充填剤、レーザー皮膚リサーフェシング、メソセラピー)
- 用途別市場(シワ、老化、ニキビ&傷跡、色素沈着過剰、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のフェイシャルスキンアブレイティブトリートメント販売量予測2017-2028
- 世界のフェイシャルスキンアブレイティブトリートメント売上予測2017-2028
- フェイシャルスキンアブレイティブトリートメントの地域別販売量
- フェイシャルスキンアブレイティブトリートメントの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別フェイシャルスキンアブレイティブトリートメント販売量
- 主要メーカー別フェイシャルスキンアブレイティブトリートメント売上
- 主要メーカー別フェイシャルスキンアブレイティブトリートメント価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(高周波(RF)マイクロニードル、皮膚充填剤、レーザー皮膚リサーフェシング、メソセラピー)
- フェイシャルスキンアブレイティブトリートメントの種類別販売量
- フェイシャルスキンアブレイティブトリートメントの種類別売上
- フェイシャルスキンアブレイティブトリートメントの種類別価格
・用途別市場規模(シワ、老化、ニキビ&傷跡、色素沈着過剰、その他)
- フェイシャルスキンアブレイティブトリートメントの用途別販売量
- フェイシャルスキンアブレイティブトリートメントの用途別売上
- フェイシャルスキンアブレイティブトリートメントの用途別価格
・北米市場
- 北米のフェイシャルスキンアブレイティブトリートメント市場規模(種類別、用途別)
- 主要国別のフェイシャルスキンアブレイティブトリートメント市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのフェイシャルスキンアブレイティブトリートメント市場規模(種類別、用途別)
- 主要国別のフェイシャルスキンアブレイティブトリートメント市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のフェイシャルスキンアブレイティブトリートメント市場規模(種類別、用途別)
- 主要国別のフェイシャルスキンアブレイティブトリートメント市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のフェイシャルスキンアブレイティブトリートメント市場規模(種類別、用途別)
- 主要国別のフェイシャルスキンアブレイティブトリートメント市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのフェイシャルスキンアブレイティブトリートメント市場規模(種類別、用途別)
- 主要国別のフェイシャルスキンアブレイティブトリートメント市場規模(トルコ、サウジアラビア)
・企業情報
Alma Lasers Ltd.、Lumenis Ltd.、Syneron Medical Ltd.、Cutera Inc.、Sciton Inc.、EL.EN. S.p.A.、Laseroptek Co. Ltd.、Fotona D.o.o.、Imdad LLC、Hologic Inc.、Stryker Corporation、Crown Laboratories Inc.、Delasco LLC、Lutronic Corp.、INSTITUTE BCN ESTHETICS SL、Koru Pharmaceuticals Co. Ltd.、CAREGEN Co. LTD.、HUGEL Inc.、Allergan plc、Galderma SA、Merz Pharma GmbH & Co. KGaA、Shenb Co. Ltd.
・産業チェーン及び販売チャネル分析
- フェイシャルスキンアブレイティブトリートメントの産業チェーン分析
- フェイシャルスキンアブレイティブトリートメントの原材料
- フェイシャルスキンアブレイティブトリートメントの生産プロセス
- フェイシャルスキンアブレイティブトリートメントの販売及びマーケティング
- フェイシャルスキンアブレイティブトリートメントの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- フェイシャルスキンアブレイティブトリートメントの産業動向
- フェイシャルスキンアブレイティブトリートメントのマーケットドライバー
- フェイシャルスキンアブレイティブトリートメントの課題
- フェイシャルスキンアブレイティブトリートメントの阻害要因
・主な調査結果

Market Analysis and Insights: Global Facial Skin Ablative Treatment Market
The global Facial Skin Ablative Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Radiofrequency (RF) Microneedling accounting for % of the Facial Skin Ablative Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Wrinkles segment is altered to an % CAGR throughout this forecast period.
China Facial Skin Ablative Treatment market size is valued at US$ million in 2021, while the North America and Europe Facial Skin Ablative Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Facial Skin Ablative Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Facial Skin Ablative Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Facial Skin Ablative Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Facial Skin Ablative Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Facial Skin Ablative Treatment market.
Global Facial Skin Ablative Treatment Scope and Market Size
Facial Skin Ablative Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Facial Skin Ablative Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Radiofrequency (RF) Microneedling
Dermal Fillers
Laser Skin Resurfacing
Mesotherapy
Segment by Application
Wrinkles
Aging
Acne and Other Scars
Hyperpigmentation
Others
By Company
Alma Lasers Ltd.
Lumenis Ltd.
Syneron Medical Ltd.
Cutera Inc.
Sciton Inc.
EL.EN. S.p.A.
Laseroptek Co. Ltd.
Fotona D.o.o.
Imdad LLC
Hologic Inc.
Stryker Corporation
Crown Laboratories Inc.
Delasco LLC
Lutronic Corp.
INSTITUTE BCN ESTHETICS SL
Koru Pharmaceuticals Co. Ltd.
CAREGEN Co. LTD.
HUGEL Inc.
Allergan plc
Galderma SA
Merz Pharma GmbH & Co. KGaA
Shenb Co. Ltd.
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Facial Skin Ablative Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Radiofrequency (RF) Microneedling
1.2.3 Dermal Fillers
1.2.4 Laser Skin Resurfacing
1.2.5 Mesotherapy
1.3 Market by Application
1.3.1 Global Facial Skin Ablative Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Wrinkles
1.3.3 Aging
1.3.4 Acne and Other Scars
1.3.5 Hyperpigmentation
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Facial Skin Ablative Treatment Market Perspective (2017-2028)
2.2 Facial Skin Ablative Treatment Growth Trends by Region
2.2.1 Facial Skin Ablative Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Facial Skin Ablative Treatment Historic Market Size by Region (2017-2022)
2.2.3 Facial Skin Ablative Treatment Forecasted Market Size by Region (2023-2028)
2.3 Facial Skin Ablative Treatment Market Dynamics
2.3.1 Facial Skin Ablative Treatment Industry Trends
2.3.2 Facial Skin Ablative Treatment Market Drivers
2.3.3 Facial Skin Ablative Treatment Market Challenges
2.3.4 Facial Skin Ablative Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Facial Skin Ablative Treatment Players by Revenue
3.1.1 Global Top Facial Skin Ablative Treatment Players by Revenue (2017-2022)
3.1.2 Global Facial Skin Ablative Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Facial Skin Ablative Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Facial Skin Ablative Treatment Revenue
3.4 Global Facial Skin Ablative Treatment Market Concentration Ratio
3.4.1 Global Facial Skin Ablative Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Facial Skin Ablative Treatment Revenue in 2021
3.5 Facial Skin Ablative Treatment Key Players Head office and Area Served
3.6 Key Players Facial Skin Ablative Treatment Product Solution and Service
3.7 Date of Enter into Facial Skin Ablative Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Facial Skin Ablative Treatment Breakdown Data by Type
4.1 Global Facial Skin Ablative Treatment Historic Market Size by Type (2017-2022)
4.2 Global Facial Skin Ablative Treatment Forecasted Market Size by Type (2023-2028)
5 Facial Skin Ablative Treatment Breakdown Data by Application
5.1 Global Facial Skin Ablative Treatment Historic Market Size by Application (2017-2022)
5.2 Global Facial Skin Ablative Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Facial Skin Ablative Treatment Market Size (2017-2028)
6.2 North America Facial Skin Ablative Treatment Market Size by Type
6.2.1 North America Facial Skin Ablative Treatment Market Size by Type (2017-2022)
6.2.2 North America Facial Skin Ablative Treatment Market Size by Type (2023-2028)
6.2.3 North America Facial Skin Ablative Treatment Market Share by Type (2017-2028)
6.3 North America Facial Skin Ablative Treatment Market Size by Application
6.3.1 North America Facial Skin Ablative Treatment Market Size by Application (2017-2022)
6.3.2 North America Facial Skin Ablative Treatment Market Size by Application (2023-2028)
6.3.3 North America Facial Skin Ablative Treatment Market Share by Application (2017-2028)
6.4 North America Facial Skin Ablative Treatment Market Size by Country
6.4.1 North America Facial Skin Ablative Treatment Market Size by Country (2017-2022)
6.4.2 North America Facial Skin Ablative Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Facial Skin Ablative Treatment Market Size (2017-2028)
7.2 Europe Facial Skin Ablative Treatment Market Size by Type
7.2.1 Europe Facial Skin Ablative Treatment Market Size by Type (2017-2022)
7.2.2 Europe Facial Skin Ablative Treatment Market Size by Type (2023-2028)
7.2.3 Europe Facial Skin Ablative Treatment Market Share by Type (2017-2028)
7.3 Europe Facial Skin Ablative Treatment Market Size by Application
7.3.1 Europe Facial Skin Ablative Treatment Market Size by Application (2017-2022)
7.3.2 Europe Facial Skin Ablative Treatment Market Size by Application (2023-2028)
7.3.3 Europe Facial Skin Ablative Treatment Market Share by Application (2017-2028)
7.4 Europe Facial Skin Ablative Treatment Market Size by Country
7.4.1 Europe Facial Skin Ablative Treatment Market Size by Country (2017-2022)
7.4.2 Europe Facial Skin Ablative Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Facial Skin Ablative Treatment Market Size (2017-2028)
8.2 Asia-Pacific Facial Skin Ablative Treatment Market Size by Type
8.2.1 Asia-Pacific Facial Skin Ablative Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Facial Skin Ablative Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Facial Skin Ablative Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Facial Skin Ablative Treatment Market Size by Application
8.3.1 Asia-Pacific Facial Skin Ablative Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Facial Skin Ablative Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Facial Skin Ablative Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Facial Skin Ablative Treatment Market Size by Region
8.4.1 Asia-Pacific Facial Skin Ablative Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Facial Skin Ablative Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Facial Skin Ablative Treatment Market Size (2017-2028)
9.2 Latin America Facial Skin Ablative Treatment Market Size by Type
9.2.1 Latin America Facial Skin Ablative Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Facial Skin Ablative Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Facial Skin Ablative Treatment Market Share by Type (2017-2028)
9.3 Latin America Facial Skin Ablative Treatment Market Size by Application
9.3.1 Latin America Facial Skin Ablative Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Facial Skin Ablative Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Facial Skin Ablative Treatment Market Share by Application (2017-2028)
9.4 Latin America Facial Skin Ablative Treatment Market Size by Country
9.4.1 Latin America Facial Skin Ablative Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Facial Skin Ablative Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Facial Skin Ablative Treatment Market Size (2017-2028)
10.2 Middle East & Africa Facial Skin Ablative Treatment Market Size by Type
10.2.1 Middle East & Africa Facial Skin Ablative Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Facial Skin Ablative Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Facial Skin Ablative Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Facial Skin Ablative Treatment Market Size by Application
10.3.1 Middle East & Africa Facial Skin Ablative Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Facial Skin Ablative Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Facial Skin Ablative Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Facial Skin Ablative Treatment Market Size by Country
10.4.1 Middle East & Africa Facial Skin Ablative Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Facial Skin Ablative Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alma Lasers Ltd.
11.1.1 Alma Lasers Ltd. Company Details
11.1.2 Alma Lasers Ltd. Business Overview
11.1.3 Alma Lasers Ltd. Facial Skin Ablative Treatment Introduction
11.1.4 Alma Lasers Ltd. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.1.5 Alma Lasers Ltd. Recent Developments
11.2 Lumenis Ltd.
11.2.1 Lumenis Ltd. Company Details
11.2.2 Lumenis Ltd. Business Overview
11.2.3 Lumenis Ltd. Facial Skin Ablative Treatment Introduction
11.2.4 Lumenis Ltd. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.2.5 Lumenis Ltd. Recent Developments
11.3 Syneron Medical Ltd.
11.3.1 Syneron Medical Ltd. Company Details
11.3.2 Syneron Medical Ltd. Business Overview
11.3.3 Syneron Medical Ltd. Facial Skin Ablative Treatment Introduction
11.3.4 Syneron Medical Ltd. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.3.5 Syneron Medical Ltd. Recent Developments
11.4 Cutera Inc.
11.4.1 Cutera Inc. Company Details
11.4.2 Cutera Inc. Business Overview
11.4.3 Cutera Inc. Facial Skin Ablative Treatment Introduction
11.4.4 Cutera Inc. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.4.5 Cutera Inc. Recent Developments
11.5 Sciton Inc.
11.5.1 Sciton Inc. Company Details
11.5.2 Sciton Inc. Business Overview
11.5.3 Sciton Inc. Facial Skin Ablative Treatment Introduction
11.5.4 Sciton Inc. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.5.5 Sciton Inc. Recent Developments
11.6 EL.EN. S.p.A.
11.6.1 EL.EN. S.p.A. Company Details
11.6.2 EL.EN. S.p.A. Business Overview
11.6.3 EL.EN. S.p.A. Facial Skin Ablative Treatment Introduction
11.6.4 EL.EN. S.p.A. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.6.5 EL.EN. S.p.A. Recent Developments
11.7 Laseroptek Co. Ltd.
11.7.1 Laseroptek Co. Ltd. Company Details
11.7.2 Laseroptek Co. Ltd. Business Overview
11.7.3 Laseroptek Co. Ltd. Facial Skin Ablative Treatment Introduction
11.7.4 Laseroptek Co. Ltd. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.7.5 Laseroptek Co. Ltd. Recent Developments
11.8 Fotona D.o.o.
11.8.1 Fotona D.o.o. Company Details
11.8.2 Fotona D.o.o. Business Overview
11.8.3 Fotona D.o.o. Facial Skin Ablative Treatment Introduction
11.8.4 Fotona D.o.o. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.8.5 Fotona D.o.o. Recent Developments
11.9 Imdad LLC
11.9.1 Imdad LLC Company Details
11.9.2 Imdad LLC Business Overview
11.9.3 Imdad LLC Facial Skin Ablative Treatment Introduction
11.9.4 Imdad LLC Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.9.5 Imdad LLC Recent Developments
11.10 Hologic Inc.
11.10.1 Hologic Inc. Company Details
11.10.2 Hologic Inc. Business Overview
11.10.3 Hologic Inc. Facial Skin Ablative Treatment Introduction
11.10.4 Hologic Inc. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.10.5 Hologic Inc. Recent Developments
11.11 Stryker Corporation
11.11.1 Stryker Corporation Company Details
11.11.2 Stryker Corporation Business Overview
11.11.3 Stryker Corporation Facial Skin Ablative Treatment Introduction
11.11.4 Stryker Corporation Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.11.5 Stryker Corporation Recent Developments
11.12 Crown Laboratories Inc.
11.12.1 Crown Laboratories Inc. Company Details
11.12.2 Crown Laboratories Inc. Business Overview
11.12.3 Crown Laboratories Inc. Facial Skin Ablative Treatment Introduction
11.12.4 Crown Laboratories Inc. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.12.5 Crown Laboratories Inc. Recent Developments
11.13 Delasco LLC
11.13.1 Delasco LLC Company Details
11.13.2 Delasco LLC Business Overview
11.13.3 Delasco LLC Facial Skin Ablative Treatment Introduction
11.13.4 Delasco LLC Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.13.5 Delasco LLC Recent Developments
11.14 Lutronic Corp.
11.14.1 Lutronic Corp. Company Details
11.14.2 Lutronic Corp. Business Overview
11.14.3 Lutronic Corp. Facial Skin Ablative Treatment Introduction
11.14.4 Lutronic Corp. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.14.5 Lutronic Corp. Recent Developments
11.15 INSTITUTE BCN ESTHETICS SL
11.15.1 INSTITUTE BCN ESTHETICS SL Company Details
11.15.2 INSTITUTE BCN ESTHETICS SL Business Overview
11.15.3 INSTITUTE BCN ESTHETICS SL Facial Skin Ablative Treatment Introduction
11.15.4 INSTITUTE BCN ESTHETICS SL Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.15.5 INSTITUTE BCN ESTHETICS SL Recent Developments
11.16 Koru Pharmaceuticals Co. Ltd.
11.16.1 Koru Pharmaceuticals Co. Ltd. Company Details
11.16.2 Koru Pharmaceuticals Co. Ltd. Business Overview
11.16.3 Koru Pharmaceuticals Co. Ltd. Facial Skin Ablative Treatment Introduction
11.16.4 Koru Pharmaceuticals Co. Ltd. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.16.5 Koru Pharmaceuticals Co. Ltd. Recent Developments
11.17 CAREGEN Co. LTD.
11.17.1 CAREGEN Co. LTD. Company Details
11.17.2 CAREGEN Co. LTD. Business Overview
11.17.3 CAREGEN Co. LTD. Facial Skin Ablative Treatment Introduction
11.17.4 CAREGEN Co. LTD. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.17.5 CAREGEN Co. LTD. Recent Developments
11.18 HUGEL Inc.
11.18.1 HUGEL Inc. Company Details
11.18.2 HUGEL Inc. Business Overview
11.18.3 HUGEL Inc. Facial Skin Ablative Treatment Introduction
11.18.4 HUGEL Inc. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.18.5 HUGEL Inc. Recent Developments
11.19 Allergan plc
11.19.1 Allergan plc Company Details
11.19.2 Allergan plc Business Overview
11.19.3 Allergan plc Facial Skin Ablative Treatment Introduction
11.19.4 Allergan plc Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.19.5 Allergan plc Recent Developments
11.20 Galderma SA
11.20.1 Galderma SA Company Details
11.20.2 Galderma SA Business Overview
11.20.3 Galderma SA Facial Skin Ablative Treatment Introduction
11.20.4 Galderma SA Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.20.5 Galderma SA Recent Developments
11.21 Merz Pharma GmbH & Co. KGaA
11.21.1 Merz Pharma GmbH & Co. KGaA Company Details
11.21.2 Merz Pharma GmbH & Co. KGaA Business Overview
11.21.3 Merz Pharma GmbH & Co. KGaA Facial Skin Ablative Treatment Introduction
11.21.4 Merz Pharma GmbH & Co. KGaA Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.21.5 Merz Pharma GmbH & Co. KGaA Recent Developments
11.22 Shenb Co. Ltd.
11.22.1 Shenb Co. Ltd. Company Details
11.22.2 Shenb Co. Ltd. Business Overview
11.22.3 Shenb Co. Ltd. Facial Skin Ablative Treatment Introduction
11.22.4 Shenb Co. Ltd. Revenue in Facial Skin Ablative Treatment Business (2017-2022)
11.22.5 Shenb Co. Ltd. Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer